To date, Okamoto et al. verified that the upregulation of G6PD and other NADPH-related redox genes could be detected in chemoresistant spheroids, indicating that G6PD may be a potential target for interfering with redox homeostasis in cancer cells to fulfill the enhancement of SDT (Yamawaki et al., 2021). This evidence concerns the gene G6PD and cancer.